I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 8 studies | 38% ± 14% | |
| plasmablast | 5 studies | 29% ± 15% | |
| CD8-positive, alpha-beta T cell | 5 studies | 19% ± 2% | |
| natural killer cell | 5 studies | 21% ± 5% | |
| hematopoietic precursor cell | 4 studies | 21% ± 9% | |
| megakaryocyte-erythroid progenitor cell | 4 studies | 24% ± 7% | |
| transit amplifying cell | 4 studies | 28% ± 7% | |
| CD4-positive, alpha-beta T cell | 4 studies | 18% ± 2% | |
| ciliated cell | 3 studies | 29% ± 16% | |
| erythroblast | 3 studies | 50% ± 16% | |
| erythrocyte | 3 studies | 30% ± 18% | |
| pancreatic ductal cell | 3 studies | 41% ± 14% | |
| abnormal cell | 3 studies | 19% ± 1% |
